Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
(Q40158643)
scientific article published on 20 February 2007
scientific article published on 20 February 2007
Language:
Current Data About
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
other details
description | scientific article published on 20 February 2007 |
External Links
(P356) |
10.1016/J.JMB.2007.02.024
|
(P698) |
17362988
|
(P8608) |
release_5wxbkwej2bdoro6xz6zilqlkzi
|